| Twin Rivers Hearing Health Inc | |
|
151 Douglas Pike #1 Smithfield RI 02917-2379 | |
| (401) 349-0456 | |
| Not Available |
| Full Name | Twin Rivers Hearing Health Inc |
|---|---|
| Speciality | Clinic/Center |
| Location | 151 Douglas Pike, Smithfield, Rhode Island |
| Authorized Official Name and Position | Mary Kay Uchmanowicz (OWNER) |
| Authorized Official Contact | 4013490456 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Twin Rivers Hearing Health Inc 151 Douglas Pike #1 Smithfield RI 02917-2379 Ph: (401) 349-0456 | Twin Rivers Hearing Health Inc 151 Douglas Pike #1 Smithfield RI 02917-2379 Ph: (401) 349-0456 |
| NPI Number | 1235319534 |
|---|---|
| Provider Enumeration Date | 11/05/2007 |
| Last Update Date | 11/05/2007 |
| Medicare PECOS PAC ID | 8224296884 |
|---|---|
| Medicare Enrollment ID | O20120228000769 |
News Archive
Sophia Genetics, the European leader in Clinical Genomics and Next Generation DNA Sequencing (NGS), has today launched a major upgrade to its Data Driven Medicine Platform (Sophia DDM), offering full BRCA1/2 analysis on a single NGS (Next Generation Sequencing) run, for the first time.
Much of what we thought we knew about the human papilloma virus (HPV) in HPV-related head and neck cancers may be wrong, according to a newly published study by Virginia Commonwealth University researchers that analyzed data from The Human Cancer Genome Atlas.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Experts are calling for more patient's to be offered bariatric surgery as a weight loss intervention for obesity.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235319534 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | (* (Not Available)) | Primary |
| 332S00000X | Hearing Aid Equipment | (* (Not Available)) | Secondary |
| Provider Name | Mary Kay Uchmanowicz |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1700899986 PECOS PAC ID: 7517125172 Enrollment ID: I20120228000759 |
News Archive
Sophia Genetics, the European leader in Clinical Genomics and Next Generation DNA Sequencing (NGS), has today launched a major upgrade to its Data Driven Medicine Platform (Sophia DDM), offering full BRCA1/2 analysis on a single NGS (Next Generation Sequencing) run, for the first time.
Much of what we thought we knew about the human papilloma virus (HPV) in HPV-related head and neck cancers may be wrong, according to a newly published study by Virginia Commonwealth University researchers that analyzed data from The Human Cancer Genome Atlas.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Experts are calling for more patient's to be offered bariatric surgery as a weight loss intervention for obesity.
› Verified 3 days ago
News Archive
Sophia Genetics, the European leader in Clinical Genomics and Next Generation DNA Sequencing (NGS), has today launched a major upgrade to its Data Driven Medicine Platform (Sophia DDM), offering full BRCA1/2 analysis on a single NGS (Next Generation Sequencing) run, for the first time.
Much of what we thought we knew about the human papilloma virus (HPV) in HPV-related head and neck cancers may be wrong, according to a newly published study by Virginia Commonwealth University researchers that analyzed data from The Human Cancer Genome Atlas.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Experts are calling for more patient's to be offered bariatric surgery as a weight loss intervention for obesity.
› Verified 3 days ago
Concentra Health Care, Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 400 Putnam Pike, Suite E, Smithfield, RI 02917 Phone: 401-232-7001 Fax: 401-232-7388 | |
Concentra Primary Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 400 Putnam Pike, Suite E, Smithfield, RI 02917 Phone: 401-232-7001 | |
Ppc, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 910 Douglas Pike, Smithfield, RI 02917 Phone: 401-459-6059 Fax: 401-427-6778 | |
Smithfield Primary Care Llc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 41 Sanderson Rd, Suite 206, Smithfield, RI 02917 Phone: 401-349-2203 Fax: 401-349-2408 | |
Vmd Primary Providers Of Rhode Island Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 400 Putnam Pike, Smithfield, RI 02917 Phone: 401-757-6160 Fax: 401-349-0840 | |
Concentra Urgent Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 400 Putnam Pike, Suite E, Smithfield, RI 02917 Phone: 401-232-7001 |